纳米载体
纳米医学
抗药性
药物输送
多重耐药
药品
纳米技术
癌症
化疗
医学
毒品携带者
药理学
生物
材料科学
纳米颗粒
内科学
微生物学
作者
Xueqing Sun,Ping Zhao,Jia Lin,Kun Chen,Jianliang Shen
出处
期刊:Cancer drug resistance
[OAE Publishing Inc.]
日期:2023-01-01
卷期号:6 (2): 390-415
被引量:7
摘要
Cancer is currently one of the most intractable diseases causing human death. Although the prognosis of tumor patients has been improved to a certain extent through various modern treatment methods, multidrug resistance (MDR) of tumor cells is still a major problem leading to clinical treatment failure. Chemotherapy resistance refers to the resistance of tumor cells and/or tissues to a drug, usually inherent or developed during treatment. Therefore, an urgent need to research the ideal drug delivery system to overcome the shortcoming of traditional chemotherapy. The rapid development of nanotechnology has brought us new enlightenments to solve this problem. The novel nanocarrier provides a considerably effective treatment to overcome the limitations of chemotherapy or other drugs resulting from systemic side effects such as resistance, high toxicity, lack of targeting, and off-target. Herein, we introduce several tumor MDR mechanisms and discuss novel nanoparticle technology applied to surmount cancer drug resistance. Nanomaterials contain liposomes, polymer conjugates, micelles, dendrimers, carbon-based, metal nanoparticles, and nucleotides which can be used to deliver chemotherapeutic drugs, photosensitizers, and small interfering RNA (siRNA). This review aims to elucidate the advantages of nanomedicine in overcoming cancer drug resistance and discuss the latest developments.
科研通智能强力驱动
Strongly Powered by AbleSci AI